·1 хв читання · 38 слів·👁 8.5K↗ 17
Mirxes applies for Singapore IPO, but may be lured by Hong Kong
Homegrown cancer diagnostics company Mirxes has made its first submission of documents to SGX for an IPO that could raise between US$100 million and US$200 million.
